E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers
HB Park, KH Baek - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The mitogen-activated protein kinase (MAPK) signaling pathway is the primary regulatory
module of various cellular processes such as cell proliferation, differentiation, and stress …
module of various cellular processes such as cell proliferation, differentiation, and stress …
Impact of ERK5 on the Hallmarks of Cancer
Extracellular signal-regulated kinase 5 (ERK5) belongs to the mitogen-activated protein
kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic …
kinase (MAPK) family that consists of highly conserved enzymes expressed in all eukaryotic …
Oncogenic signaling of MEK5-ERK5
VT Hoang, TJ Yan, JE Cavanaugh, PT Flaherty… - Cancer letters, 2017 - Elsevier
Mitogen-activated protein kinases (MAPKs) regulate diverse cellular processes including
proliferation, cell survival, differentiation, and apoptosis. While conventional MAPK …
proliferation, cell survival, differentiation, and apoptosis. While conventional MAPK …
Clinical significance and regulation of ERK5 expression and function in cancer
M Monti, J Celli, F Missale, F Cersosimo, M Russo… - Cancers, 2022 - mdpi.com
Simple Summary Alterations of the MEK5/ERK5 signaling pathway have been described in
several tumors, and emerging data are trying to explain the complexity of ERK5-related …
several tumors, and emerging data are trying to explain the complexity of ERK5-related …
Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment
DM Sosnoski, RJ Norgard, CD Grove, SJ Foster… - Clinical & experimental …, 2015 - Springer
Breast cancer can reoccur, often as bone metastasis, many years if not decades after the
primary tumor has been treated. The factors that stimulate dormant metastases to grow are …
primary tumor has been treated. The factors that stimulate dormant metastases to grow are …
CircPUM1 promotes hepatocellular carcinoma progression through the miR‐1208/MAP3K2 axis
Y Zhang, D Wang, T Zhu, J Yu, X Wu… - Journal of Cellular …, 2021 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a common disease with a significant mortality, and there
is no effective treatment for advanced patients. Growing evidence indicates that circRNAs …
is no effective treatment for advanced patients. Growing evidence indicates that circRNAs …
The oncoprotein HBXIP enhances migration of breast cancer cells through increasing filopodia formation involving MEKK2/ERK1/2/Capn4 signaling
Y Li, Z Zhang, X Zhou, L Li, Q Liu, Z Wang, X Bai… - Cancer letters, 2014 - Elsevier
We have reported that the oncoprotein hepatitis B X-interacting protein (HBXIP) plays a
crucial role in the promotion of migration of breast cancer cells. Lamellipodia and filopodia …
crucial role in the promotion of migration of breast cancer cells. Lamellipodia and filopodia …
Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis
H Yang, W Li, Y Lv, Q Fan, X Mao, T Long, L Xie… - Gene, 2019 - Elsevier
Clear cell renal cell carcinoma (ccRCC) is a highly invasive urological malignant tumor that
results in shorter patient survival. At present, the mechanism of ccRCC metastasis is not …
results in shorter patient survival. At present, the mechanism of ccRCC metastasis is not …
[HTML][HTML] Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast
P Sun, Z Zhong, Q Lu, M Li, X Chao, D Chen, W Hu… - Modern Pathology, 2020 - Elsevier
Micropapillary features are seen in pure mucinous carcinoma of breast (PMC), which is
termed mucinous carcinoma with micropapillary features (MPMC). However, whether MPMC …
termed mucinous carcinoma with micropapillary features (MPMC). However, whether MPMC …
Cysteine cathepsins inhibition affects their expression and human renal cancer cell phenotype
M Rudzińska, A Parodi, VD Maslova, YM Efremov… - Cancers, 2020 - mdpi.com
Renal cancer would greatly benefit from new therapeutic strategies since, in advanced
stages, it is refractory to classical chemotherapeutic approaches. In this context, lysosomal …
stages, it is refractory to classical chemotherapeutic approaches. In this context, lysosomal …